Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQ3C2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $208,060
Award facts
- Contract value 100% obligated
- $208,059.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DOVATO 50-300 mg tablets (30-count units) with a ceiling value of $208,059.77. This firm fixed-price delivery order, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. DOVATO (dolutegravir/lamivudine), an antiretroviral medication used in HIV treatment, aligns with the company's established role supplying specialized pharmaceutical products to support military healthcare programs worldwide and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FQ3C2?
SPE2DB25FQ3C2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQ3C2 worth?
The government has obligated $208,060 on SPE2DB25FQ3C2.
Is contract SPE2DB25FQ3C2 an order under another contract?
Yes. SPE2DB25FQ3C2 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ3C2 competed?
The extent of competition for SPE2DB25FQ3C2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award